TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Day One Biopharmaceuticals
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

Day One Biopharmaceuticals announced it will acquire Mersana Therapeutics for approximately $129 million, expanding its oncology portfolio with the antibody-drug conjugate emiltatug ledadotin (Emi-Le), which shows early anti-tumor activity in adenoid cystic carcinoma treatment.

Insights
DAWN   positive

Acquiring a promising therapeutic asset that expands portfolio and potential for patient impact, with no additional financing required